Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis.

Small
John C ChappellRichard J Price

Abstract

Therapeutic strategies in which recombinant growth factors are injected to stimulate arteriogenesis in patients suffering from occlusive vascular disease stand to benefit from improved targeting, less invasiveness, better growth-factor stability, and more sustained growth-factor release. A microbubble contrast-agent-based system facilitates nanoparticle deposition in tissues that are targeted by 1-MHz ultrasound. This system can then be used to deliver poly(D,L-lactic-co-glycolic acid) nanoparticles containing fibroblast growth factor-2 to mouse adductor muscles in a model of hind-limb arterial insufficiency. Two weeks after treatment, significant increases in both the caliber and total number of collateral arterioles are observed, indicating that the delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction may represent an effective and minimally invasive strategy for the targeted stimulation of therapeutic arteriogenesis.

References

Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·D M BrownR K Khouri
Apr 17, 1997·Nature·W Risau
Nov 2, 2001·Nature Biotechnology·T P RichardsonD J Mooney
Feb 1, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Niels van RoyenWolfgang Schaper
Mar 19, 2002·International Journal of Pharmaceutics·Jasmine Davda, Vinod Labhasetwar
Jul 9, 2002·Journal of Molecular and Cellular Cardiology·Dimitri ScholzWolfgang Schaper
Feb 26, 2003·Circulation Research·Elisabeth DeindlWolfgang Schaper
Mar 19, 2003·Circulation·Timothy D HenryUNKNOWN VIVA Investigators
Jun 5, 2003·Nature Medicine·Seppo Ylä-Herttuala, Kari Alitalo
Dec 12, 2003·Nature Reviews. Drug Discovery·Michael Simons, J Anthony Ware
Apr 2, 2004·Nature·Robert Langer, David A Tirrell
Sep 17, 2005·European Heart Journal·David VancraeynestJean-Louis J Vanoverschelde
Oct 15, 2005·Ultrasound in Medicine & Biology·John C ChappellRichard J Price
Jun 21, 2006·Ultrasound in Medicine & Biology·Robyn K SchlicherMark R Prausnitz
Dec 28, 2006·Pharmaceutical Research·Ruth R ChenDavid J Mooney
Jun 2, 2007·Advanced Drug Delivery Reviews·Marina Sokolsky-PapkovAbraham J Domb

❮ Previous
Next ❯

Citations

Jul 10, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Gregory M LanzaSamuel A Wickline
May 6, 2009·Pharmaceutical Research·Sufeng Zhang, Hasan Uludağ
Jul 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Rituparna Sinha RoyShiladitya Sengupta
Apr 17, 2012·Journal of Drug Delivery·Marxa Figueiredo, Rinat Esenaliev
Apr 13, 2012·Vascular Medicine·Geoffrey O OumaEmile R Mohler
May 3, 2013·International Journal of Nanomedicine·Ying-Zheng ZhaoShu-Ping Ge
Jan 6, 2011·Journal of Visualized Experiments : JoVE·Caitlin W Burke, Richard J Price
Jul 11, 2013·Nanomedicine·Christian Oliver PritzRudolf Glueckert
Nov 8, 2011·Therapeutic Delivery·Brian E O'Neill, Natalya Rapoport
Jan 15, 2014·Best Practice & Research. Clinical Endocrinology & Metabolism·Ying Liu, Gary Sweeney
Nov 1, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Caitlin W BurkeRichard J Price
Dec 3, 2014·Ultrasound in Medicine & Biology·Rick F J KwekkeboomRené J P Musters
Mar 10, 2015·International Journal of Molecular Sciences·Zheng ZhaoMao-Bin Xie
Oct 25, 2012·Expert Opinion on Drug Delivery·Odile DiouElias Fattal
Dec 30, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ying-Zheng ZhaoCui-Tao Lu
Feb 23, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fabienne DanhierVéronique Préat
Aug 13, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Charles F CaskeyKatherine W Ferrara
Oct 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ashim K MitraDhananjay Pal
Sep 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kelsie F TimbieRichard J Price
Jun 26, 2012·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Natalya Rapoport
Jan 5, 2013·IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control·Lee B MullinPaul A Dayton
Mar 1, 2016·ACS Biomaterials Science & Engineering·Navindee C WickremasingheJeffrey D Hartgerink
Nov 26, 2015·Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology·Y-H HsiangR J Price
Jun 5, 2014·Clinical Science·Rick F J KwekkeboomJoost P G Sluijter
Apr 18, 2016·Journal of Shoulder and Elbow Surgery·Justin C KennonLynn A Crosby
Feb 11, 2015·Biomedical Microdevices·Ali H DhanaliwalaJohn A Hossack
Jul 7, 2015·Biomaterials Science·S SuarezK L Christman
Mar 13, 2018·Advanced Healthcare Materials·Zhanfeng LiXuejun Cui
Dec 2, 2017·Journal of the American Heart Association·Joshua L HeusleinRichard J Price
May 30, 2019·Biomolecules·Benjamin D WhiteHelen E Townley
Feb 16, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Rahul MittalRahul Dev Jayant
Nov 22, 2011·Nanotechnology·Rituparna Sinha RoyShiladitya Sengupta
Jun 27, 2019·International Journal of Molecular Sciences·Catherine M GorickRichard J Price

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.